Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Emma Bolam

Head of Production

After graduating with a biology degree, I worked in a NHS clinical immunology laboratory for three years. I then joined the University’s Therapeutic Antibody Centre for almost ten years, generating cell lines and producing and testing monoclonal antibodies for clinical trials. Since the CBF was established in 2005, I have helped develop and produce more than 20 different vaccines for clinical trials. I am a qualified auditor of GMP Pharmaceutical Quality Systems and now have almost 25 years’ experience in GMP for Investigational Medicinal Products.  In April 2020, the CBF’s production team manufactured the UK’s first COVID-19 vaccine (ChAdOx1 nCoV-19).